Skip to content

Robot-Assisted Hand Motor Therapy for Subjects With Hemiparetic Stroke

Robot-Assisted Hand Motor Therapy for Subjects With Hemiparetic Stroke

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01244243
Acronym
Robot3
Enrollment
41
Registered
2010-11-19
Start date
2009-01-31
Completion date
2012-12-31
Last updated
2016-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, rehabilitation

Brief summary

The purpose of this study is to develop and assess the effectiveness of robot-assisted movement therapy in enhancing hand motor function in subjects with chronic hemiparetic stroke, and to identify predictors of treatment response.

Interventions

DEVICEHand & Wrist Assisting Robotic Device

Treatment occurs in 2 hour sessions, 4 times a week over 3 weeks. In each treatment session, you will sit in a chair and have your weak hand attached to a mechanical device (the robot), which will help you open and close your hand. During the treatment, different types of objects (with varying shapes, sizes, and weight) will be placed into your hand. You will be given a variety of instructions related to the grasping, feeling, or identifying of the object in your hand. Sometimes these instructions will be given from the investigator and sometimes from the computer. You will often be asked to grasp, or release, each of these objects as best you can. You will also be asked to concentrate on the object in your hand. An example of what you may be asked to do is to name the object. During other times, you will play games, using the robot to control game parts on the computer screen. At other times, you will move your hand so that the robot can measure your hand function.

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. At least 18 years old 2. Had stroke between 11-26 weeks ago 3. Have some weakness in one of your wrists or hands due to stroke 4. Did not have too much disability prior to stroke 5. Do not have major depression

Exclusion criteria

1. Non-English speaking 2. If you have trouble keeping good attention 3. Pregnant, advanced liver, kidney, heart, or lung disease 4. Terminal medical diagnosis or major neurological or psychiatric disease apart from stroke 5. Cannot undergo MRI scanning 6. Have history of brain surgery or seizures

Design outcomes

Primary

MeasureTime frameDescription
Action Research Arm Testchange from baseline to 1 month post-end treatment, Intention To TreatThe Action Research Arm Test is a 19 item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from: 3: Performs test normally 2: Completes test, but takes abnormally long or has great difficulty 1: Performs test partially 0: Can perform no part of test. The test is used to determine upper limb function, 0-57 points with higher is better, 57 is the highest score indicating normal arm movement.
Arm Motor Fugl-Meyer Testchange from baseline to 1 month post-end treatment, Intention To TreatThe Arm Motor Fugl-Meyer test is an assessment of Sensorimotor Recovery After Stroke. It is a 33 item measure with 3 subgroups which are Proximal, Wrist/Hand, and Coordination/Speed. The scaling for each item works on a scale of 0-2 with 0 being not able to be done, 1 being partially done, and 2 being done normally. The scoring goes from 0-66, higher is better, 66 is considered a normal score with no noticable complications in movement.

Countries

United States

Participant flow

Participants by arm

ArmCount
Active Therapy
All subjects receive the same active robotic therapy, there is no placebo arm, as a key goal of this study is to define predictors of response to active treatment. Hand & Wrist Assisting Robotic Device: Treatment occurs in 2 hour sessions, 4 times a week over 3 weeks.
41
Total41

Baseline characteristics

CharacteristicActive Therapy
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
Age, Continuous59 years
STANDARD_DEVIATION 14
Region of Enrollment
United States
41 participants
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
30 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 41
serious
Total, serious adverse events
0 / 41

Outcome results

Primary

Action Research Arm Test

The Action Research Arm Test is a 19 item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from: 3: Performs test normally 2: Completes test, but takes abnormally long or has great difficulty 1: Performs test partially 0: Can perform no part of test. The test is used to determine upper limb function, 0-57 points with higher is better, 57 is the highest score indicating normal arm movement.

Time frame: change from baseline to 1 month post-end treatment, Intention To Treat

ArmMeasureValue (MEAN)
Active TherapyAction Research Arm Test4.1 units on a scale
Primary

Arm Motor Fugl-Meyer Test

The Arm Motor Fugl-Meyer test is an assessment of Sensorimotor Recovery After Stroke. It is a 33 item measure with 3 subgroups which are Proximal, Wrist/Hand, and Coordination/Speed. The scaling for each item works on a scale of 0-2 with 0 being not able to be done, 1 being partially done, and 2 being done normally. The scoring goes from 0-66, higher is better, 66 is considered a normal score with no noticable complications in movement.

Time frame: change from baseline to 1 month post-end treatment, Intention To Treat

ArmMeasureValue (MEAN)
Active TherapyArm Motor Fugl-Meyer Test3.7 units on a scale

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026